American College of Cardiology Announces First Hospitals to Participate in the Patient Navigator Program


Alisha Martin

Patients with Acute Coronary Syndrome (ACS) face many difficulties as they transition from the hospital back to their home following a cardiovascular event. It is critical they understand at discharge the next steps in their road to recovery.

A recent JAMA Internal Medicine study looked at transitional care after hospitalization and found that a fourth of discharge instructions were written in medical jargon that a patient was not likely to understand.

AstraZeneca became the founding sponsor of the American College of Cardiology (ACC) Patient Navigator Program,contributing $10 million to this program earlier this year. The program was designed to help cardiology patients through the challenges of transitioning from hospital to home following their heart attack.

Today, the ACC announced the first hospitals selected to be a part of its program:

The ACC Patient Navigator Program will provide personalized support to patients with ACS at these hospitals based on their specific needs, which is vital because cardiovascular disease impacts every patient differently.

The ACC Patient Navigator Program aligns with AstraZeneca’s desire to put patients at the core of everything we do and our commitment to finding new ways to support patients’ health.